Mirum Pharmaceuticals (MIRM) Other Gross PP&E Adjustments (2020 - 2025)
Historic Other Gross PP&E Adjustments for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to -$21.4 million.
- Mirum Pharmaceuticals' Other Gross PP&E Adjustments fell 192.03% to -$21.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$21.4 million, marking a year-over-year decrease of 192.03%. This contributed to the annual value of -$21.2 million for FY2024, which is 13002.71% down from last year.
- Per Mirum Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at -$21.4 million for Q3 2025, which was down 192.03% from -$23.0 million recorded in Q2 2025.
- Over the past 5 years, Mirum Pharmaceuticals' Other Gross PP&E Adjustments peaked at -$4.0 million during Q4 2021, and registered a low of -$23.0 million during Q2 2025.
- In the last 5 years, Mirum Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$9.2 million in 2023 and averaged -$11.8 million.
- As far as peak fluctuations go, Mirum Pharmaceuticals' Other Gross PP&E Adjustments surged by 192.4% in 2021, and later tumbled by 16700.41% in 2024.
- Over the past 5 years, Mirum Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$4.0 million in 2021, then plummeted by 68.93% to -$6.8 million in 2022, then crashed by 35.6% to -$9.2 million in 2023, then plummeted by 130.03% to -$21.2 million in 2024, then dropped by 0.8% to -$21.4 million in 2025.
- Its last three reported values are -$21.4 million in Q3 2025, -$23.0 million for Q2 2025, and -$21.6 million during Q1 2025.